Prostate cancer screening and beliefs about treatment efficacy: A national survey of primary care physicians and urologists

American Journal of Medicine

Volumn 104, Issue 6, 1998, Pages 526-532

  Fowler Jr , Floyd J ^a   Bin, Lin ^a   McNaughton Collins, Mary ^b   Roberts, Richard G ^c   Oesterling, Joseph E ^d   Wasson, John H ^e   Barry, Michael J ^b  

^a UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d Midwest Prostate Institute   (United States)

^e DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER SCREENING; CONSERVATIVE TREATMENT; FEMALE; GENERAL PRACTITIONER; HUMAN; MALE; MEDICAL PRACTICE; MEDICAL SPECIALIST; NORMAL HUMAN; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; TREATMENT OUTCOME; UROLOGY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FAMILY PRACTICE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERNAL MEDICINE; LIFE EXPECTANCY; MALE; MASS SCREENING; MIDDLE AGED; PRIMARY HEALTH CARE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; REFERRAL AND CONSULTATION; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES; UROLOGY;

EID: 0032104307     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(98)00124-7     Document Type: Article

References (17)

1. 1. Potosky AL, Miller BA, Albertsen PC, et al. The role of increasing detection in the rising incidence of prostate cancer. JAMA. 1995; 273:548-552.
2. 2. Jacobsen SJ, Katusic SK, Bergstralh EJ, et al. Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing. JAMA. 1995;274:1445-1449.
3. 3. Barry MJ, Fleming C, Coley CM, et al. Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part I: framing the debate. Urology. 1995; 46:2-13.
4. 4. Mandelson MT, Wagner EH, Thompson RS. PSA screening: a public health dilemma. Ann Rev Pub Health. 1995;16:283-306.
5. 5. Mettlin C, Jones G, Averette H, et al. Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers. CA Cancer J Clin. 1993; 43:42-47.
6. 6. Prostate Cancer: What Every Man over 40 Should Know. Baltimore: Prostate Health Council; 1994.
7. 7. U.S. Preventive Services Task Force. Screening for prostate cancer. In: Guide to Clinical Preventive Services. 2d ed. Baltimore: Williams and Wilkins; 1996:119-134.
8. 8. Canadian Task Force on the Periodic Health Examination. Periodic health examination, 1991 update: 3. Secondary prevention of prostate cancer. Can Med Assoc J. 1991;145:413-428.
9. 9. U.S. Preventive Services Task Force. Screening for prostate cancer: a commentary on the Canadian Task Force on the Periodic Health Examination 1991 update on the secondary prevention of prostate cancer. Am J Prev Med. 1994;10:187-193.
10. 10. Ruckle HC, Klee GG, Oesterling JE. Prostate-specific antigen: critical issues for the practicing physician. Mayo Clin Proc. 1994;69:59-68.
11. 11. Walsh PC. Prostate cancer kills: strategy to reduce deaths. Urology. 1994;44:463-466.
12. 12. Middleton RG, Thompson IM, Austenfeld MS, et al. Prostate Cancer Clinical Guidelines Panel summary report on the management of clinically localized prostate cancer. J Urol. 1995;154:2144-2148.
13. 13. Barry MJ, Fleming C, Coley C, et al. Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part IV: estimating the risks and benefits of an early detection program. Urology. 1995;46:445-461.
14. 14. Statistical Abstract of the United States: 1993. 113th ed. Washington, DC: US Bureau of the Census; 1993.
15. 15. Moore MJ, O'Sullivan B, Tannock IF. How expert physicians would wish to be treated if they had genitourinary cancer. J Clin Oncol. 1988;6:1736-1745.
16. 16. Wennberg DE, Dickens JD Jr, Biener L, et al. Do physicians do what they say? The inclination to test and its associations with coronary angiography rates. J Gen Intern Med. 1997;12:172-176.
17. 17. Hahn D, Roberts RG. PSA screening for asymptomatic prostate cancer: truth in advertising. J Fam Pract. 1993;37:432-435.